Skip to main content
INMB logo

INMB · Inmune Bio, Inc. · Documents

Track INMB — free
$0.89 -0.01 (-0.70%) Play latest call Q3 2026 earnings call transcript
Market Cap
$27.68M
Shares
30.96M
Volume · Nov 20 19.48K Avg daily vol (3M) 342.92K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2024
Mar 28
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $155K ▼ 58.6% Net loss $30.01M Diluted EPS -$1.67
2023
Mar 2
Annual report 10-K FY2022, ended Dec 31
Annual report for FY2022
Revenue $374K ▲ 106.6% Net loss $27.3M Diluted EPS -$1.52
Showing 101–150 of 313 documents
Key facts CIK 1711754 CUSIP 45782T105 13F (30d) 70 filings 58 filers Visit website Investor relations